Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Pharmaceutical Manufacturing
Argenta is a Pharmaceutical Manufacturing brand in Auckland, New Zealand. Ownership is privately held; it publishes at argentaglobal.com. The record carries seven addresses across five office countries. The record counts 514 people. Tagged animal health, consultancy and technology transfer. Its latest round on record is Private equity, US$30.0M. It is listed alongside eight similar brands, mostly in Pharmaceutical Manufacturing.
At Argenta, we’ve been collaborating with clients worldwide since 2006, bringing expertise, innovation, and a can-do attitude to deliver cutting-edge animal health & nutrition, and human nutrition solutions.
Why Argenta?
We are the only global CRO and CDMO focused exclusively on animal health & nutrition, complemented by regulatory expertise in human nutrition. We provide tailored, end-to-end solutions from Molecule to Market at any scale.
Our Three Pillars:
- Global Partnerships – turning ideas into reality worldwide
- Molecule to Market Approach – guiding products from research to launch
- Innovation – driving progress in animal & nutrition, and human nutrition
Our Services:
- R&D: innovative animal health & nutrition solutions, fully EMA/FDA/EFSA compliant
- Pre-Clinical Research: dedicated teams in Spain, Germany, and the US providing confident go/no-go decisions
- Clinical Research: agile, high-quality veterinary studies delivered on time and within budget
- GMP Manufacturing: facilities in New Zealand, the US, and the UK
- Regulatory & Scientific Consultancy: expert support for medicinal products, feed additives, and human nutrition products (novel foods, food additives, enzymes, etc)
- Full Product Development: from concept to market
Collaboration at Our Core:
950+ experts in science, veterinary, engineering, and regulatory affairs, working closely with clients to develop products that truly make an impact.
Our Story:
Founded in New Zealand by scientist Doug Cleverly, Argenta combines Kiwi ingenuity with global collaboration. Our roots as a trusted CRO go back to 1987, built on scientific excellence and long-term partnerships.
Today, through our CMO & CDMO facilities, we optimize efficacy trials, accelerate product development, and help companies turn innovative ideas into market-ready products.
We also support human nutrition projects, guiding companies through regulatory pathways to successfully launch new products.
Let’s make it happen - together!
| Countries | 5 |
|---|---|
| Primary country | NZ |
All codes: NZ DE ES GB US
| Rounds | 1 |
|---|---|
| Axis | 2006 to 2026 |
| Private equity · 20 Jun 2021 | US$ 30.0M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
The record holds 514 counted staff profiles at January 2026, inside the self-reported 501–1,000 band.
Seven addresses on record across 5 countries. Primary: 2 Sterling Ave, Auckland, New Zealand 2243.
One round. Latest 20 June 2021: private equity, US$30,000,000, investor Novaquest Capital Management.
15 tags on the brand's own list, among them animal health, consultancy and technology transfer.
29 profiles list Argenta as a peer — 96th percentile in Pharmaceutical Manufacturing. It lists ten peers of its own. GMP Pharmaceuticals Ltd and Vitaco Group list it back.